Page last updated: 2024-10-28

mephentermine and Heart Failure

mephentermine has been researched along with Heart Failure in 2 studies

Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FRYE, RL1
KAHLER, RL1
BRAUNWALD, E1
AGRESS, CM1

Reviews

1 review available for mephentermine and Heart Failure

ArticleYear
THERAPY OF CARDIOGENIC SHOCK.
    Progress in cardiovascular diseases, 1963, Volume: 6

    Topics: Angiotensins; Cardiac Tamponade; Heart Aneurysm; Heart Diseases; Heart Failure; Humans; Hydromorphon

1963

Other Studies

1 other study available for mephentermine and Heart Failure

ArticleYear
The ineffectiveness of an inotropic agent, mephentermine (Wyamine), in the treatment of congestive heart failure.
    American heart journal, 1961, Volume: 62

    Topics: Cardiovascular Agents; Heart Failure; Humans; Mephentermine

1961